BPC-157

Mechanism of Action:

BPC 157, a pentadecapeptide, has a complex mechanism of action that is not yet fully understood.

Benefits:

  1. Promotion of Tendon Healing: BPC 157 promotes tendon healing by enhancing tendon outgrowth, cell survival, and cell migration. This is likely mediated by the activation of the FAK-paxillin pathway.

  2. Growth Hormone Receptor Expression: BPC 157 has been shown to enhance the expression of growth hormone receptors in tendon fibroblasts, which could contribute to its healing effects.

  3. Angiogenesis: BPC 157 appears to activate a protein known as VEGFR2, which then activates a particular pathway (VEGFR2-Akt-eNOS) that is involved in angiogenesis, or the formation of new blood vessels.

  4. Neuroprotective Effects: BPC 157 has been shown to counteract inflammatory and non-inflammatory pain, resolve neuronal damage, and prevent memory, locomotor, and coordination deficits. It exerts these effects by altering gene expression in the hippocampus.

  5. Gene Expression: BPC 157's action initially affects the expression of particular genes (i.e., Akt1, Grb2, Nos3, Pik3cd, Prkcg, Ptk2, Src). Then, it involves another set of genes (Braf, Egfr, Egr1, Hdac7, Mapk1, Mapk3, Mapk14, Plcg1, Prkcg, Ptk2, Pxn, Src, Srf, and Vegfa). Subsequently, it concludes with an additional set of genes (i.e., Kras). These interactions may represent the complex way of how the action, which will eventually resolve the lesion, may start and progress.

Side effects:

  1. Nausea: Some users have reported feeling nauseous after taking BPC 157.

  2. Dizziness: Dizziness is another potential side effect of BPC 157.

  3. Hot or Cold Flashes: Some users have reported experiencing hot or cold flashes after taking BPC 157.

  4. Fatigue: Fatigue is another potential side effect, although it's not clear how common this is.

  5. Headaches: Some users have reported experiencing headaches after taking BPC 157.

  6. Changes in Appetite or Weight: Changes in appetite or weight have been reported, although it's not clear how common this is.

  7. Pain and Inflammation at the Injection Site: Since BPC 157 is often administered via injection, pain and inflammation at the injection site are common side effects.

  8. Blood Pressure Fluctuations: Some users have reported fluctuations in blood pressure after taking BPC 157.

  9. Liver and Kidney Complications: While not common, there have been reports of liver and kidney complications associated with BPC 157 use.

  10. Mood Swings: Some users have reported experiencing mood swings after taking BPC 157.

Interactions:

BPC 157, a synthetic peptide, is known to interact with several systems in the body. Here are some key interactions:

  1. Dopaminergic System: BPC 157 has been shown to interact with the dopamine system. It can block the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. When used alone, BPC 157 does not affect gross behavior or induce stereotypy.

  2. Adrenergic System: BPC 157 interacts with the adrenergic system, specifically with alpha and beta receptors. The involvement of beta-receptor stimulation in BPC 157 gastroprotection appears to be related to the route of BPC 157 administration. A strong protection, noted following intragastric or intraperitoneal administration of BPC 157, was fully abolished by coadministration of phentolamine, clonidine, and haloperidol, and consistently not affected by prazosin, yohimbine, or domperidone. Atenolol abolished only intraperitoneal BPC 157 protection, whereas propranolol affected specifically intragastric BPC 157 protection.

  3. Nitric Oxide Synthesis: BPC 157 promotes nitric oxide synthesis, which is involved in various physiological processes, including vasodilation, neurotransmission, and immune response.

  4. Calcium Channels: BPC 157 has been found to modulate calcium channels, ensuring the appropriate influx and efflux of calcium ions in cardiac cells. This regulation helps maintain the balance of calcium, preventing abnormalities in heart muscle contraction and supporting overall cardiac function.

Dosing Guidelines:

  • Intramuscular or Subcutaneous Injection:

    • The typical dosage for recovery from overuse injuries is 250-500 micrograms per day, divided into multiple injections.

    • For intramuscular injection, the typical dosage is 200 to 300 micrograms per day, in a single daily injection, taken consistently each day for up to 4 weeks.

  • Oral Administration:

    • For oral administration, the dose is typically 500 micrograms per day.

  • Duration of Use:

    • It is recommended to take BPC 157 consistently daily for up to 3 months, then give it a break for one month.

  • Starting Dose for New Users:

    • New users are recommended to begin with a lower dosage and gradually build up, with suggestions starting from 300 – 600 micrograms per day.

**The information provided on this post is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption

Back to blog

Leave a comment